J. Coche

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
J.-c. Coche, J-c Coche, Jean-charles Coche, J C Coche, Jean-charles R Coche, Jc Coche, J. Coche, J-c. Coche
Publication record
43 papers · 1,738 citations · H-index 11

PAPERS

Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus.
202310 citationsauthor #18
Immune checkpoint inhibitor refractory colitis leading to total colectomy in a melanoma patient.
20233 citationsauthor #8
397P R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer
202116 citationsauthor #13
P600 Vedolizumab dose optimisation: Findings from a Belgian registry
20201 citationsauthor #14
P603 Persistence of vedolizumab maintenance therapy: Findings from a Belgian registry
20201 citationsauthor #14
P131 Effectiveness and safety of vedolizumab maintenance therapy for inflammatory bowel disease: findings from a Belgian registry
20190 citationsauthor #14
P694 Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients
20190 citationsauthor #5
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumab.
20188 citationsauthor #5
The second case of a young man with l-arginine-induced acute pancreatitis
201810 citationsauthor #7
Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO)
20177 citationsauthor #22
Type of treating physician is associated with long-term disease outcome in the prospective Belgian paediatric Crohn’s disease registry (BELCRO)
20160 citationsauthor #22
Abstract presented at the 21st Annual Congress of the Belgian Society of Internal Medicine - Joint meeting with the Belgian Society of Infectiology and Clinical Microbiology
20160 citationsauthor #2
Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian registry of paediatric Crohn's disease (BELCRO)
20160 citationsauthor #19
Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up
20169 citationsauthor #20
Tailored step-up approach results in beneficial long-term disease outcome in the prospective Belgian Paediatric Crohn's disease registry (BELCRO)
20160 citationsauthor #22
UEG Week 2016 Poster Presentations
20169 citationsauthor #3397
Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer
201523 citationsauthor #3
Randomized phase II studies comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab or cetuximab with FOLFOX or FOLFIRI.
20150 citationsauthor #9
P495 Efficacy of switching to infliximab in Crohn's disease patients with loss of response to adalimumab
20141 citationsauthor #5
Profile of pediatric Crohn's disease in Belgium.
201338 citationsauthor #24
Use of biologicals in a pediatric crohn’s disease cohort
20120 citationsauthor #17
Phase II trial of preoperative radiotherapy (RT) and panitumumab (PAN) in KRAS wild type (wt) rectal cancer (RC).
20120 citationsauthor #3
P320 Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn's disease patients (BELCRO)
20120 citationsauthor #23
Factors determining therapeutic strategy at diagnosis and evolution of disease severity in a cohort of Belgian pediatric Crohn’s disease patients (BELCRO)
20120 citationsauthor #23
Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease.
20124 citationsauthor #18
Profile of Belgian Pediatric Crohn's Disease Patients: Presentation and diagnostic features
20111 citationsauthor #23
Profile of Belgian Pediatric Crohn's Disease (CD) Patients: Associations Between Variables at Diagnosis
20110 citationsauthor #23
Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution.
200929 citationsauthor #2
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
20081,130 citationsauthor #13
Peptic ulcer disease associated with Helicobacter felis in a dog owner.
200727 citationsauthor #5
A combined regimen of infliximab and azathioprine induces better endoscopic healing than classic step-up therapy in newly diagnosed Crohn's disease
200628 citationsauthor #8
Gastric ulcer disease associated with Helicobacter felis in a person and multiple gastric non-Helicobacter pylori helicobacters in her dog
20060 citationsauthor #4
Phase I study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.
20069 citationsauthor #4
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.
2006161 citationsauthor #4
Phase I/II study of preoperative cetuximab, capecitabine and external beam radiotherapy in patients with locally advanced rectal cancer (LARC)
20050 citationsauthor #2
Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: the RadiOxCape study.
2005134 citationsauthor #5
A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma. : Abstract #3552
20040 citationsauthor #5
A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma.
20049 citationsauthor #5
260 A phase II study of preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with locally advanced rectal adenocarcinoma: the RadiOxCape study
20039 citationsauthor #4
A Belgian traveler who acquired yellow fever in the Gambia.
200248 citationsauthor #3
Budd-Chiari syndrome likely related to a slimming drug preparation.
19951 citationsauthor #1
[Gastric cancer: a long-term consequence of Helicobacter pylori infection?].
199411 citationsauthor #3
Le cancer gastrique : une conséquence à long terme de l'infection à Helicobacter pylori ?
19940 citationsauthor #3

TIMELINE

1994 11 citations

1995 1 citations

2002 48 citations

2003 9 citations

2004 9 citations

2005 134 citations

2006 198 citations

2007 27 citations

2008 1,130 citations

2009 29 citations

2011 1 citations

2012 4 citations

2013 38 citations

2014 1 citations

2015 23 citations

2016 18 citations

2017 7 citations

2018 18 citations

2019 0 citations

2020 2 citations

2021 16 citations

2023 13 citations

J. Coche

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT